$20,000 of ACADIA PHARMACEUTICALS INC. lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Tax Reform - Restoring the Orphan Drug Tax Credit."
You can find more data on corporate lobbying on Quiver Quantitative.
ACAD Insider Trading Activity
ACAD insiders have traded $ACAD stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $ACAD stock by insiders over the last 6 months:
- MARK C. SCHNEYER (EVP, CHIEF FINANCIAL OFFICER) has made 0 purchases and 4 sales selling 23,647 shares for an estimated $663,637.
- JAMES KIHARA (PRINCIPAL ACCOUNTING OFFICER) has made 0 purchases and 3 sales selling 18,154 shares for an estimated $441,329.
- ELIZABETH H.Z. THOMPSON (EVP, Head of Research & Dev) has made 0 purchases and 2 sales selling 16,558 shares for an estimated $432,662.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
ACAD Hedge Fund Activity
We have seen 172 institutional investors add shares of ACAD stock to their portfolio, and 141 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FIRST TRUST ADVISORS LP removed 3,159,482 shares (-94.5%) from their portfolio in Q2 2026, for an estimated $79,934,894
- MARSHALL WACE, LLP added 1,688,651 shares (+2216.5%) to their portfolio in Q2 2026, for an estimated $42,722,870
- QUBE RESEARCH & TECHNOLOGIES LTD added 1,496,311 shares (+157.5%) to their portfolio in Q2 2026, for an estimated $37,856,668
- TRAILS EDGE CAPITAL PARTNERS, LP removed 1,419,406 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $35,910,971
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,206,336 shares (+inf%) to their portfolio in Q2 2026, for an estimated $30,520,300
- GOLDMAN SACHS GROUP INC added 1,022,311 shares (+65.6%) to their portfolio in Q2 2026, for an estimated $25,864,468
- BLACKROCK, INC. added 964,252 shares (+4.5%) to their portfolio in Q2 2026, for an estimated $24,395,575
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
ACAD Price Targets
Multiple analysts have issued price targets for $ACAD recently. We have seen 4 analysts offer price targets for $ACAD in the last 6 months, with a median target of $35.5.
Here are some recent targets:
- Brian Abrahams from RBC Capital set a target price of $36.0 on 07/07/2026
- Tazeen Ahmad from B of A Securities set a target price of $30.0 on 06/30/2026
- Yigal Nochomovitz from Citigroup set a target price of $35.0 on 06/29/2026
- Sumant Kulkarni from Canaccord Genuity set a target price of $36.0 on 06/29/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
